Screener
Taysha Gene Therapies, Inc. TSHA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$46.64M-73.5% | -$42.41M-97.0% | -$27.85M-48.3% | -$32.73M-28.2% | -$26.88M-28.4% | ||
| $400K+33.3% | $295K+4.2% | $299K-1.6% | $200K-33.3% | $300K0.0% | ||
| $5.81M+82.1% | $5.55M+68.4% | $3.53M+9.7% | $3.29M-2.1% | $3.19M-4.3% | ||
| -$40.43M-100% | -$40.88M-85.6% | -$26.72M-46.0% | -$24.17M-11.8% | -$20.18M+6.1% | ||
| —— | $24K-93.7% | $250K— | $108K+209% | $2K-99.0% | ||
| —— | -$3.02M-715% | -$247K— | -$48K-37.1% | —— | ||
| $216.66M+0.2% | $711K+1,467% | $49.56M— | $8.8M+33.4% | $216.29M+207% | ||
| $176.23M-10.2% | -$43.19M-92.4% | $22.59M+221% | $0+100% | $196.17M+302% | ||
| -$40.42M-100% | -$40.9M-82.6% | -$26.97M-47.3% | -$24.27M-12.1% | -$20.18M+7.0% |
FAQ
- How much cash does Taysha Gene Therapies, Inc. generate?
- Taysha Gene Therapies, Inc. (TSHA) generated -$132.2M in operating cash flow over the trailing twelve months.
- What is Taysha Gene Therapies, Inc.'s free cash flow?
- Taysha Gene Therapies, Inc.'s free cash flow was -$132.6M over the trailing twelve months, down 60.6% year over year.
- Where does Taysha Gene Therapies, Inc.'s cash flow data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
